Beijing YiSaiSi International Trade lnc – Trademark Portfolio
Entity Type: 99
Beijing YiSaiSi International Trade lnc holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 21 (Housewares) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include GEKEOVO, SRAWNRA, and IMAMURA HEALTHCARE. The owner is based in Beijing.
Rm South 101,Building3,No.46 Xishuncheng
Beijing 100000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Beijing YiSaiSi International Trade lnc's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Beijing YiSaiSi International Trade lnc have?
Beijing YiSaiSi International Trade lnc has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does Beijing YiSaiSi International Trade lnc file in?
Beijing YiSaiSi International Trade lnc files trademarks across 3 Nice Classification classes. The most active classes are Class 21 (Housewares), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 21 covers household or kitchen utensils and containers; combs and sponges; brushes.
What are Beijing YiSaiSi International Trade lnc's most well-known trademarks?
Beijing YiSaiSi International Trade lnc's registered trademark portfolio includes well-known marks such as GEKEOVO, SRAWNRA, and IMAMURA HEALTHCARE. These are among 4 currently registered trademarks in the portfolio.
What is Beijing YiSaiSi International Trade lnc's trademark registration success rate?
Beijing YiSaiSi International Trade lnc has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.